The good news is Saliba isn't going under the knife. The bad news is Arsenal have lost their best defender for God knows how long, and a back injury with no surgery doesn't mean a quick fix — it means weeks on a treatment table with no end date guaranteed.
Arsenal confirmed the update without putting a timeline on it. "Extended period" is the phrase they've settled on, which tells you everything and nothing at the same time. No surgery is a relief in isolation, but don't let the club's carefully managed language fool you into thinking this is minor.
What We Actually Know
Saliba has a back injury. Arsenal say he won't need surgery. He will miss an extended period. That is the full picture as it stands — and the honesty of how thin that update is should bother every Arsenal supporter.
Back injuries are notoriously stubborn. They don't follow a neat rehabilitation schedule. You can avoid the operating theatre and still spend months trying to get a player back to full match fitness. The absence of surgery is not the same as a short-term problem. It just means the solution is rest, recovery, and hope — and none of those come with a fixed return date.
As we've already written, [this injury is a serious problem Arsenal cannot ignore](/getohedz/football/saliba-injury-is-a-serious-problem-arsenal-cannot-ignore). Saliba isn't just a good defender — he is the defensive structure Arsenal have built everything around. Without him, the back line is genuinely exposed in a way the squad depth doesn't comfortably cover.
The Timing Is as Bad as It Gets
Arsenal are in the thick of a title race and a European campaign simultaneously. Losing your first-choice centre-back at any point would hurt. Losing him now, without a clear return date, and with no surgery to at least give you a recovery milestone to plan around, is a different kind of problem.
The squad will have to adapt. Mikel Arteta will rotate and reorganise. Arsenal aren't without options in defence — but there's a significant gap between "we have cover" and "we have a replacement for Saliba." Nobody in that squad is William Saliba.
There's also a transfer angle worth watching. The New York Times reported that John Stones has emerged as a target for Arsenal, which makes all the sense in the world given the situation. Whether that move is realistic — financially, logistically, or in terms of Manchester City's willingness to sell — is another question entirely. But the fact it's being discussed tells you the club are aware the current options may not be enough.
Our Take
No surgery is the best possible version of a bad situation, and we'll take it. But Arsenal and their supporters need to stop treating "avoided the worst" as good news. An extended absence for your most important outfield player, with no timeline attached, is a genuine problem — not a manageable inconvenience dressed up in positive framing.
Arteta will do his job. The squad will grind through it. But if Arsenal end this season without a trophy and Saliba's injury is a factor, the question of why this wasn't addressed in the transfer market earlier will be asked loudly. And rightly so.